The Type 1 Diabetes Clinical Research Network (T1DCRN) has made a significant announcement this week with the release of a major report on the deployment of the $35 million investment by the Australian Government. The report also gives new insight to how Australians will soon have unprecedented opportunities to participate in research through clinical trials.
Director of the T1DCRN, Dr Dorota Pawlak, said that the T1DCRN is a new approach to type 1 diabetes research. “We collaborate, we nurture future leaders, we bring expertise from outside conventional T1D research into the Network. By working together in new ways we believe we are making progress more quickly.”
The report describes how, led by JDRF Australia, the T1DCRN is beginning to positively impact the lives of people with type 1 diabetes, in Australia and worldwide through the support and promotion of clinical research. JDRF’s role is bringing together advocates and government to ensure that the T1DCRN is driving research progress in Australia.
Activation of Australia’s best scientists
The report details the impact of the more than $20 million in funding that has been awarded so far to Australia’s best scientists and clinicians in 2014 and 2015 through the T1DCRN.
Dr Pawlak said that she is particularly pleased to see that patients are already engaged in clinical trials, and that this would increase significantly over the coming years. “Some of the technologies that were trialled since 2010 are now on the brink of becoming accessible elements of routine disease management,” said Dr Pawlak.
A bright future
The current focus for the T1DCRN is innovation, with a series of compelling applications being considered by an expert panel right now. “We’re looking for strong ideas that fall outside current T1D research paradigms,” said Dr Pawlak. “We’re also committed to research outcomes, we are working with our funded projects to meet benchmarks, timelines and agreed targets.”
Clinical research needs you
Dr Pawlak sent her thanks to the many people who have played a part in bringing the goal of the T1DCRN closer to reality for people living with type 1 diabetes. She also put out a new call to the T1D community.
“In the past JDRF may have called on you to join an event or make a donation. In the next year or two we will ask for something different: sign up to be part of clinical research, or as a first step, just find out more.”
“You might be surprised by how safe and easy clinical research can be. One thing is sure; it’s one of the most important things you’ll ever do to help us achieve our goal more quickly.”